UN Group of Friends to Eliminate Hepatitis Solidarity for Hepatitis Elimination | 2nd Annual Meeting

UN Group of Friends to Eliminate Hepatitis Solidarity for Hepatitis Elimination | 2nd Annual Meeting

September 22 2023
08:00 AM
Webinar series
UN Group of Friends to Eliminate Hepatitis
UNGA 2023 Event

Session 1 | 8:00 am – 9:30 am EDT | Strengthening Political Commitment and Global Solidarity for Hepatitis Elimination: Hepatitis service integration via UHC

Welcome Remarks

  • Dr. Patrick O’Carroll, President & CEO, The Task Force for Global Health
  • Dr. John W. Ward, Director, The Coalition for Global Hepatitis Elimination
  • Dr. Werner Obermeyer, Director, WHO Office at the United Nations

Opening Statement | Nobel Laureate, Dr. Harvey Alter, National Institutes of Health

Remarks from the Leadership Circle

  • Egypt | Ambassador Ahmed ElshandawilyDeputy Permanent Representative of the Arab Republic of Egypt to the UN
  • Portugal | Ambassador Jorge ArandaDeputy Permanent Representative, Mission of Portugal to the UN
  • Chile | Mrs. Andrea PeñaJefa Programa Nacional de Hepatitis B y C, Ministerio de Salud de Chile

Progress towards elimination of hepatitis in the context of UHC | Dr. Meg Doherty, Director Global HIV, Hepatitis and STI Programmes, World Health Organization (WHO)

Strengthening health systems to eliminate hepatitis in Africa | H.E. Dr. Jean KaseyaDirector General, Africa CDC, Dr. Wessam Mankoula, Ag. Head, RCC North, Africa CDC

Building capacity for responses to endemic and epidemic threats | Dr. Rebecca Bunnell, Acting Principal Deputy Coordinator, PEPFAR, Global Health Security and Diplomacy Bureau, US Deptartment of State

Commitment to Health Diplomacy and Benefiting the Cause of Hepatitis Elimination

  • Egypt | Minister Khaled Abdel-GhaffarMinister of Health and Population, The Egyptian Ministry of Health and Population
  • Ghana | Dr. Anthony Nsiah-Asare, Presidential Advisor on Health, Office of the President Ghana
  • Pakistan | Prof Saeed AkhterChairman, Pakistan Kidney and Liver Institute and Research Center
  • Korea | Republic of Dr. Youngmee JeeCommissioner, Korea Disease Control and Prevention Agency
  • Ukraine | Dr. Olga GvozdetskaActing Deputy General Director, Public Health Center of the Ministry of Health, Ukraine
  • Somalia | Dr. Ali Haji AdamMinister of Health and Human Services, Ministry of Health, Somalia
  • Malaysia | Dr. Husnina Ibrahim, Deputy Director (Communicable Disease), Disease Control Division, Ministry of Health
  • Portugal | H.E. Manuel PizarroMinister of Health, Portuguese Republic
  • Mexico | Dr. Alethse De La Torre RosasDirector of the National Center for the Prevention and Control of HIV and AIDS, Government of Mexico

Closing | Dr. John W. Ward, Director, The Coalition for Global Hepatitis Elimination

---------------------------------------------------------------------------------------------------

Session 2 | 11:00 am - 12:30 pm EDT | Elimination of Mother-to-Child Transmission of Hepatitis B virus: Achievement of the UN SDG 

Opening Statement | Nobel Laureate, Dr. Harvey Alter, National Institutes of Health (NIH)

Progress toward achievement of the UN SDG for hepatitis B elimination | Dr. John W. Ward, Director, The Coalition for Global Hepatitis Elimination

Remembering the faces behind the numbers – person centered prevention and care | Dr. Danjuma Adda, President, World Hepatitis Alliance

Supporting hepatitis B vaccination beginning at birth | Dr. Viorica Berdaga, Deputy Chief Immunization, UNICEF

Recent introduction of hepatitis B birth dose vaccination | Ethiopia, Dr. Tsion Firew, Advisor to the Minister of Health of Ethiopia, Columbia University Medical Center

The role of Gavi in helping countries implement hepatitis B birth dose vaccination | Dr. Simbarashe Mabaya, Senior Technical Advisor and Hep B-BD Focal Point, Gavi

Recent introduction of hepatitis B birth dose vaccination in Uganda | Dr. Herbert Nabaasa, Commissioner of Environmental Health, Ministry of Health, Uganda

Role of CDC in support of elimination of mother-to-child transmission of hepatitis B virus | Dr. Rania Tohme | Associate Director for Global Health, Division of Viral Hepatitis, US Centers for Disease Control and Prevention (US CDC)

Taking steps toward hepatitis B birth dose vaccination

  • Malawi | Minister Khumbize ChipondaHonourable Minister, Ministry of Health, Malaw
  • Georgia | Minister Zurab AzarashviliMinister of Health, The Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Affairs of Georgia
  • Burkina Faso | Prof. Mahamoudou SanouProfessor of Bacteriology Virology, Hospital Center University Pediatric – Charles De Gaulle

Support for EMTCT, antenatal screening and hepatitis B birth dose: Gathering the political will for health equity needed to defeat hepatitis

  • Dr. Weigong Zhou, Vaccine Preventable Hepatitis Focal Point, WHO Regional Office for the Western Pacific
  • Dr. Leandro SerenoMedical Officer and Hepatitis Focal Point, Pan American Health Organization (PAHO), WHO Regional Office for the Americas
  • Dr. Meg DohertyDirector Global HIV, Hepatitis and STI Programmes, WHO
  • Dr. Danjuma AddaPresident, World Hepatitis Alliance
  • Dr. David DuongDirector, Program in Global Primary Care and Social Change, Harvard Medical School
  • Dr. Su WangGlobal Health Advisor, Hepatitis B Foundation
  • Lindsey Hiebert-Suwondo, Associate Director, The Coalition for Global Hepatitis Elimination
  • Renuka GaddeSenior Advisor, Clinton Health Access Initiative, Inc. (CHAI)

Closing | Dr. John W. Ward, Director, The Coalition for Global Hepatitis Elimination

Contact the Coalition at globalhep [at] taskforce.org

There are no partners for this webinar.
There are no presenters for this webinar.
There are no sponsors for this webinar.